Literature DB >> 33798991

T2* placental MRI in pregnancies complicated with fetal congenital heart disease.

Johannes K Steinweg1, Grace Tin Yan Hui2, Maximilian Pietsch3, Alison Ho2, Milou Pm van Poppel4, David Lloyd5, Kathleen Colford2, John M Simpson5, Reza Razavi5, Kuberan Pushparajah5, Mary Rutherford2, Jana Hutter3.   

Abstract

BACKGROUND: Congenital heart disease (CHD) is one of the most important and common group of congenital malformations in humans. Concurrent development and close functional links between the fetal heart and placenta emphasise the importance of understanding placental function and its influence in pregnancy outcomes. The aim of this study was to evaluate placental oxygenation by relaxometry (T2*) to assess differences in placental phenotype and function in CHD.
METHODS: In this prospective cross-sectional observational study, 69 women with a fetus affected with CHD and 37 controls, whole placental T2* was acquired using a 1.5-Tesla MRI scanner. Gaussian Process Regression was used to assess differences in placental phenotype in CHD cohorts compared to our controls.
RESULTS: Placental T2* maps demonstrated significant differences in CHD compared to controls at equivalent gestational age. Mean T2* values over the entire placental volume were lowest compared to predicted normal in right sided obstructive lesions (RSOL) (Z-Score 2.30). This cohort also showed highest lacunarity indices (Z-score -1.7), as a marker of lobule size. Distribution patterns of T2* values over the entire placental volume were positively skewed in RSOL (Z-score -4.69) and suspected, not confirmed coarctation of the aorta (CoA-) (Z-score -3.83). Deviations were also reflected in positive kurtosis in RSOL (Z-score -3.47) and CoA- (Z-score -2.86).
CONCLUSION: Placental structure and function appear to deviate from normal development in pregnancies with fetal CHD. Specific patterns of altered placental function assessed by T2* deliver crucial complementary information to antenatal assessments in the presence of fetal CHD.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Congenital heart disease (CHD); Gaussian process regression (GPR); Machine learning; Magnetic resonance imaging (MRI); Placenta; T2* Mapping

Mesh:

Year:  2021        PMID: 33798991      PMCID: PMC7611398          DOI: 10.1016/j.placenta.2021.02.015

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  50 in total

1.  Cloprostenol, a prostaglandin F(2alpha) analog, induces hypoxia in rat placenta: BOLD contrast MRI.

Authors:  Eliezer Girsh; Vicki Plaks; Assaf A Gilad; Nava Nevo; Edna Schechtman; Michal Neeman; Nava Dekel
Journal:  NMR Biomed       Date:  2007-02       Impact factor: 4.044

2.  Placental baseline conditions modulate the hyperoxic BOLD-MRI response.

Authors:  Marianne Sinding; David A Peters; Sofie S Poulsen; Jens B Frøkjær; Ole B Christiansen; Astrid Petersen; Niels Uldbjerg; Anne Sørensen
Journal:  Placenta       Date:  2017-11-07       Impact factor: 3.481

3.  Consensus Based Definition of Growth Restriction in the Newborn.

Authors:  Irene M Beune; Frank H Bloomfield; Wessel Ganzevoort; Nicholas D Embleton; Paul J Rozance; Aleid G van Wassenaer-Leemhuis; Klaske Wynia; Sanne J Gordijn
Journal:  J Pediatr       Date:  2018-02-28       Impact factor: 4.406

4.  Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life.

Authors:  C E G Head; V C Jowett; G K Sharland; J M Simpson
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

5.  Statistical validation of image segmentation quality based on a spatial overlap index.

Authors:  Kelly H Zou; Simon K Warfield; Aditya Bharatha; Clare M C Tempany; Michael R Kaus; Steven J Haker; William M Wells; Ferenc A Jolesz; Ron Kikinis
Journal:  Acad Radiol       Date:  2004-02       Impact factor: 3.173

6.  Congenital Heart Defects and Indices of Fetal Cerebral Growth in a Nationwide Cohort of 924 422 Liveborn Infants.

Authors:  Niels B Matthiesen; Tine B Henriksen; J William Gaynor; Peter Agergaard; Cathrine C Bach; Vibeke E Hjortdal; John R Østergaard
Journal:  Circulation       Date:  2016-01-14       Impact factor: 29.690

7.  MR Imaging-derived Oxygen-Hemoglobin Dissociation Curves and Fetal-Placental Oxygen-Hemoglobin Affinities.

Authors:  Reut Avni; Ofra Golani; Ayelet Akselrod-Ballin; Yonni Cohen; Inbal Biton; Joel R Garbow; Michal Neeman
Journal:  Radiology       Date:  2016-01-14       Impact factor: 11.105

8.  Understanding Heterogeneity in Clinical Cohorts Using Normative Models: Beyond Case-Control Studies.

Authors:  Andre F Marquand; Iead Rezek; Jan Buitelaar; Christian F Beckmann
Journal:  Biol Psychiatry       Date:  2016-01-06       Impact factor: 13.382

9.  Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.

Authors:  Alec J Hirsch; Victoria H J Roberts; Peta L Grigsby; Nicole Haese; Matthias C Schabel; Xiaojie Wang; Jamie O Lo; Zheng Liu; Christopher D Kroenke; Jessica L Smith; Meredith Kelleher; Rebecca Broeckel; Craig N Kreklywich; Christopher J Parkins; Michael Denton; Patricia Smith; Victor DeFilippis; William Messer; Jay A Nelson; Jon D Hennebold; Marjorie Grafe; Lois Colgin; Anne Lewis; Rebecca Ducore; Tonya Swanson; Alfred W Legasse; Michael K Axthelm; Rhonda MacAllister; Ashlee V Moses; Terry K Morgan; Antonio E Frias; Daniel N Streblow
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

10.  Perfusion and apparent oxygenation in the human placenta (PERFOX).

Authors:  Jana Hutter; Anita A Harteveld; Laurence H Jackson; Suzanne Franklin; Clemens Bos; Matthias J P van Osch; Jonathan O'Muircheartaigh; Alison Ho; Lucy Chappell; Joseph V Hajnal; Mary Rutherford; Enrico De Vita
Journal:  Magn Reson Med       Date:  2019-08-21       Impact factor: 4.668

View more
  1 in total

1.  Understanding the Maternal-Fetal Environment and the Birth of Prenatal Pediatrics.

Authors:  Catherine Limperopoulos; David L Wessel; Adre J du Plessis
Journal:  J Am Heart Assoc       Date:  2022-01-11       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.